Dexamethasone Interferes with Autophagy and Affects Cell Survival in Irradiated Malignant Glioma Cells
Alfred Komakech, Ji-Hye Im, Ho-Shin Gwak, Kyue-Yim Lee, Jong Heon Kim, Byong Chul Yoo, Heesun Cheong, Jong Bae Park, Ji Woong Kwon, Sang Hoon Shin, Heon Yoo
J Korean Neurosurg Soc. 2020;63(5):566-578. Published online 2020 Apr 10 DOI: https://doi.org/10.3340/jkns.2019.0187
Citations to this article as recorded by 
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
Marilin S Koch, Mykola Zdioruk, Michal O Nowicki, Alec M Griffith, Estuardo Aguilar, Laura K Aguilar, Brian W Guzik, Francesca Barone, Paul P Tak, Ghazaleh Tabatabai, James A Lederer, E Antonio Chiocca, Sean Lawler
Journal for ImmunoTherapy of Cancer.2022; 10(1): e003368. CrossRef
Advantages and drawbacks of dexamethasone in glioblastoma multiforme
Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, Farzaneh Shakeri, Bahram Bibak, Zakieh Keshavarzi, Mohammad Soukhtanloo, Mohammad Jalili-Nik, Mohammad Montazami Sadeghi, Hamid Mollazadeh, Thomas P. Johnston, Amirhossein Sahebkar
Critical Reviews in Oncology/Hematology.2022; 172: 103625. CrossRef
Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma
Lourdes Sainero-Alcolado, Muhammad Mushtaq, Judit Liaño-Pons, Aida Rodriguez-Garcia, Ye Yuan, Tong Liu, María Victoria Ruiz-Pérez, Susanne Schlisio, Oscar Bedoya-Reina, Marie Arsenian-Henriksson
Journal of Experimental & Clinical Cancer Research.2022;[Epub] CrossRef
Autophagy activation in breast cancer cells in vitro after the treatment with PI3K/AKT/mTOR inhibitors
D. D. Grigoreva, E. M. Zhidkova, E. S. Lylova, A. D. Enikeev, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, E. A. Lesovaya
Advances in Molecular Oncology.2022; 9(4): 61. CrossRef